본문 바로가기

Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q2
저널
CELL DEATH DISCOVERY8(1) · #450 · 2022
피인용
Web of Science 23Scopus 23
FWCI (Scopus)
0.7
JCR IF
JCR 2021 7.113
ISSN
2058-7716

저자

  1. Mun, Jeong-Yeon제1저자Dong A Univ, Dept Biomed Sci, Busan 49315, South Korea
  2. Baek, Seung-WooKorea Res Inst Biosci & Biotechnol KRIBB, Daejeon 34141, South Korea
  3. Jeong, Mi-SoDong A Univ, Dept Biomed Sci, Busan 49315, South Korea
  4. Jang, In-HwanKorea Res Inst Biosci & Biotechnol KRIBB, Daejeon 34141, South Korea
  5. Lee, Se-RaOsong Med Innovat Fdn KBio, Div Drug Dev & Optimizat, Daejeon 28160, Chungbuk, South Korea
  6. You, Jae-YoungKorea Basic Sci Inst, Ctr Sci Instrumentat, Daejeon 28119, Chungbuk, South Korea
  7. Kim, Jeong-AhKorea Basic Sci Inst, Ctr Sci Instrumentat, Daejeon 28119, Chungbuk, South Korea
  8. Yang, Gi-EunDong A Univ, Dept Biomed Sci, Busan 49315, South Korea
  9. Choi, Yung-HyunDong Eui Univ, Antiaging Res Ctr, Dept Biochem, Coll Oriental Med, Busan 47227, South Korea
  10. 김태남Pusan Natl Univ Hosp, Med Res Inst, Dept Urol, Busan 49241, South Korea
  11. Chu, In-Sun교신저자Korea Res Inst Biosci & Biotechnol KRIBB, Daejeon 34141, South Korea
  12. Leem, Sun-Hee교신저자Dong A Univ, Dept Biomed Sci, Busan 49315, South Korea

초록

Chemotherapy resistance is an obstacle to cancer therapy and is considered a major cause of recurrence. Thus, understanding the mechanisms of chemoresistance is critical to improving the prognosis of patients. Here, we have established a stepwise gemcitabine-resistant T24 bladder cancer cell line to understand the molecular mechanisms of chemoresistance within cancer cells. The characteristics of the stepwise chemoresistance cell line were divided into 4 phases (parental, early, intermediate, and late phases). These four phase cells showed increasingly aggressive phenotypes in vitro and in vivo experiments with increasing phases and revealed the molecular properties of the biological process from parent cells to phased gemcitabine-resistant cell line (GRC). Taken together, through the analysis of gene expression profile data, we have characterized gene set of each phase indicating the response to anticancer drug treatment. Specifically, we identified a multigene signature (23 genes including GATA3, APOBEC3G, NT5E, MYC, STC1, FOXD1, SMAD9) and developed a chemoresistance score consisting of that could predict eventual responsiveness to gemcitabine treatment. Our data will contribute to predicting chemoresistance and improving the prognosis of bladder cancer patients.

키워드

EPITHELIAL-MESENCHYMAL TRANSITIONDRUG-RESISTANCECHEMOTHERAPYGEMCITABINENEOADJUVANTEVOLUTIONPROGRESSIONMETASTASISACTIVATIONPROGNOSIS

식별자

Scopus EID
2-s2.0-85141545358
WoS UID
000879785400002